209 related articles for article (PubMed ID: 3946507)
1. Kell sensitization in pregnancy.
Caine ME; Mueller-Heubach E
Am J Obstet Gynecol; 1986 Jan; 154(1):85-90. PubMed ID: 3946507
[TBL] [Abstract][Full Text] [Related]
2. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
Wenk RE; Goldstein P; Felix JK
Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
[TBL] [Abstract][Full Text] [Related]
3. The significance of anti-Kell sensitization in pregnancy.
Mayne KM; Bowell PJ; Pratt GA
Clin Lab Haematol; 1990; 12(4):379-85. PubMed ID: 2081378
[TBL] [Abstract][Full Text] [Related]
4. Death in utero due to Kell sensitization without excessive elevation of the delta OD450 value in amniotic fluid.
Berkowitz RL; Beyth Y; Sadovsky E
Obstet Gynecol; 1982 Dec; 60(6):746-9. PubMed ID: 7145281
[No Abstract] [Full Text] [Related]
5. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
[TBL] [Abstract][Full Text] [Related]
6. [Kell antibodies in pregnancy].
Rempen A; Schweppe KW
Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
[TBL] [Abstract][Full Text] [Related]
7. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
[TBL] [Abstract][Full Text] [Related]
8. [Hemolytic disease of the newborn due to Kell sensitization].
Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
[No Abstract] [Full Text] [Related]
9. Obstetric outcome after RhD and Kell testing.
Lipitz S; Many A; Mitrani-Rosenbaum S; Carp H; Frenkel Y; Achiron R
Hum Reprod; 1998 Jun; 13(6):1472-5. PubMed ID: 9688374
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin.
Dhodapkar KM; Blei F
J Pediatr Hematol Oncol; 2001 Jan; 23(1):69-70. PubMed ID: 11196277
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of extended analysis of serum, amniotic fluid and cardiotocography in the management of pregnancy complicated by immunization in Rh or Kell antigens.
Woytoń J; Narczewska B; Gajewska E; Baranowski H; Kwoczyńska K; Dzierzkowa-Borodej W; Partyka T; Bochenek S; Lochocka E
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1131-7. PubMed ID: 107916
[TBL] [Abstract][Full Text] [Related]
12. Maternal Kell blood group alloimmunization.
Bowman JM; Pollock JM; Manning FA; Harman CR; Menticoglou S
Obstet Gynecol; 1992 Feb; 79(2):239-44. PubMed ID: 1731292
[TBL] [Abstract][Full Text] [Related]
13. Anti-Kell in pregnancy.
Leggat HM; Gibson JM; Barron SL; Reid MM
Br J Obstet Gynaecol; 1991 Feb; 98(2):162-5. PubMed ID: 2004052
[TBL] [Abstract][Full Text] [Related]
14. Management of pregnancies complicated by anti-Kell isoimmunization.
McKenna DS; Nagaraja HN; O'Shaughnessy R
Obstet Gynecol; 1999 May; 93(5 Pt 1):667-73. PubMed ID: 10912964
[TBL] [Abstract][Full Text] [Related]
15. [Perinatal research on feto-maternal anti-Kell immunization].
Gavriil P; Jauniaux E; Lambermont M; Donner C; Avni FE; Rodesch F
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):761-4. PubMed ID: 2689503
[TBL] [Abstract][Full Text] [Related]
16. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia.
Weiner CP; Widness JA
Am J Obstet Gynecol; 1996 Feb; 174(2):547-51. PubMed ID: 8623782
[TBL] [Abstract][Full Text] [Related]
17. Management of pregnancies complicated by anti-E alloimmunization.
Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietic suppression in fetal anemia because of Kell alloimmunization.
Vaughan JI; Warwick R; Letsky E; Nicolini U; Rodeck CH; Fisk NM
Am J Obstet Gynecol; 1994 Jul; 171(1):247-52. PubMed ID: 8030708
[TBL] [Abstract][Full Text] [Related]
19. Current clinical management of anti-Kell alloimmunization in pregnancy.
Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
[TBL] [Abstract][Full Text] [Related]
20. Erythroblastosis fetalis produced by anti-k.
Bowman JM; Harman FA; Manning CR; Pollock JM
Vox Sang; 1989; 56(3):187-9. PubMed ID: 2728396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
